Trafficking of surfactant protein A in fetal rabbit lung in organ culture

J. L. Alcorn, C. R. Mendelson

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Surfactant protein A (SP-A), a major protein component of pulmonary surfactant, is a developmentally and hormonally regulated sialoglycoprotein expressed in type II pneumonocytes. Surfactant proteins and glycerophospholipids are transported to multilamellar structures termed lamellar bodies, which serve to store surfactant lipoprotein until secretion by exocytosis into the alveolar lumen. The cellular mechanism(s) for targeting of SP-A and other surfactant components to lamellar bodies is unknown. In the present study, we have investigated the transport of SP-A to lamellar bodies in fetal rabbit lung tissue in organ culture using pulse- chase analysis of [35S]-methionine-labeled SP-A protein. SP-A accumulated in lamellar bodies within 1-3 h of synthesis; lamellar body SP-A was found to be endoglycosidase H resistant and represented 30-40% of the radiolabeled SP- A recovered from the tissue for periods of up to 12 h postlabeling. Based on our estimates of lamellar body recovery from tissue homogenates, lamellar body-associated SP-A may account for 60-80% of the SP-A present in the fetal lung explants. Treatment of fetal rabbit lung explants with inhibitors of oligosaccharide addition (tunicamycin) and processing (castanospermine), which act within the endoplasmic reticulum, significantly reduced the rate of transport of newly synthesized SP-A to lamellar bodies. An inhibitor of oligosaccharide processing that acts on a processing step that takes place within the Golgi apparatus (swainsonine) reduced the rate of transport of radiolabeled SP-A to lamellar bodies by ~50%. These results suggest that a large proportion of newly synthesized SP-A is transported to lamellar bodies and that the transport of SP-A to lamellar bodies is enhanced by the presence of an N-linked oligosaccharide side chain and may depend on N-linked oligosaccharide processing.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume264
Issue number1 8-1
StatePublished - 1993

Fingerprint

Pulmonary Surfactant-Associated Protein A
Organ Culture Techniques
Rabbits
Lung
Oligosaccharides
Surface-Active Agents
Carrier Proteins
Swainsonine
Sialoglycoproteins
Glycerophospholipids
Pulmonary Surfactants
Tunicamycin
Proteins
Glycoside Hydrolases
Exocytosis
Golgi Apparatus
Endoplasmic Reticulum
Methionine
Lipoproteins

Keywords

  • glycosylation
  • lamellar bodies
  • secretion

ASJC Scopus subject areas

  • Cell Biology
  • Physiology
  • Pulmonary and Respiratory Medicine

Cite this

@article{67c1cdb790bf4166856c7e4955caf647,
title = "Trafficking of surfactant protein A in fetal rabbit lung in organ culture",
abstract = "Surfactant protein A (SP-A), a major protein component of pulmonary surfactant, is a developmentally and hormonally regulated sialoglycoprotein expressed in type II pneumonocytes. Surfactant proteins and glycerophospholipids are transported to multilamellar structures termed lamellar bodies, which serve to store surfactant lipoprotein until secretion by exocytosis into the alveolar lumen. The cellular mechanism(s) for targeting of SP-A and other surfactant components to lamellar bodies is unknown. In the present study, we have investigated the transport of SP-A to lamellar bodies in fetal rabbit lung tissue in organ culture using pulse- chase analysis of [35S]-methionine-labeled SP-A protein. SP-A accumulated in lamellar bodies within 1-3 h of synthesis; lamellar body SP-A was found to be endoglycosidase H resistant and represented 30-40{\%} of the radiolabeled SP- A recovered from the tissue for periods of up to 12 h postlabeling. Based on our estimates of lamellar body recovery from tissue homogenates, lamellar body-associated SP-A may account for 60-80{\%} of the SP-A present in the fetal lung explants. Treatment of fetal rabbit lung explants with inhibitors of oligosaccharide addition (tunicamycin) and processing (castanospermine), which act within the endoplasmic reticulum, significantly reduced the rate of transport of newly synthesized SP-A to lamellar bodies. An inhibitor of oligosaccharide processing that acts on a processing step that takes place within the Golgi apparatus (swainsonine) reduced the rate of transport of radiolabeled SP-A to lamellar bodies by ~50{\%}. These results suggest that a large proportion of newly synthesized SP-A is transported to lamellar bodies and that the transport of SP-A to lamellar bodies is enhanced by the presence of an N-linked oligosaccharide side chain and may depend on N-linked oligosaccharide processing.",
keywords = "glycosylation, lamellar bodies, secretion",
author = "Alcorn, {J. L.} and Mendelson, {C. R.}",
year = "1993",
language = "English (US)",
volume = "264",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 8-1",

}

TY - JOUR

T1 - Trafficking of surfactant protein A in fetal rabbit lung in organ culture

AU - Alcorn, J. L.

AU - Mendelson, C. R.

PY - 1993

Y1 - 1993

N2 - Surfactant protein A (SP-A), a major protein component of pulmonary surfactant, is a developmentally and hormonally regulated sialoglycoprotein expressed in type II pneumonocytes. Surfactant proteins and glycerophospholipids are transported to multilamellar structures termed lamellar bodies, which serve to store surfactant lipoprotein until secretion by exocytosis into the alveolar lumen. The cellular mechanism(s) for targeting of SP-A and other surfactant components to lamellar bodies is unknown. In the present study, we have investigated the transport of SP-A to lamellar bodies in fetal rabbit lung tissue in organ culture using pulse- chase analysis of [35S]-methionine-labeled SP-A protein. SP-A accumulated in lamellar bodies within 1-3 h of synthesis; lamellar body SP-A was found to be endoglycosidase H resistant and represented 30-40% of the radiolabeled SP- A recovered from the tissue for periods of up to 12 h postlabeling. Based on our estimates of lamellar body recovery from tissue homogenates, lamellar body-associated SP-A may account for 60-80% of the SP-A present in the fetal lung explants. Treatment of fetal rabbit lung explants with inhibitors of oligosaccharide addition (tunicamycin) and processing (castanospermine), which act within the endoplasmic reticulum, significantly reduced the rate of transport of newly synthesized SP-A to lamellar bodies. An inhibitor of oligosaccharide processing that acts on a processing step that takes place within the Golgi apparatus (swainsonine) reduced the rate of transport of radiolabeled SP-A to lamellar bodies by ~50%. These results suggest that a large proportion of newly synthesized SP-A is transported to lamellar bodies and that the transport of SP-A to lamellar bodies is enhanced by the presence of an N-linked oligosaccharide side chain and may depend on N-linked oligosaccharide processing.

AB - Surfactant protein A (SP-A), a major protein component of pulmonary surfactant, is a developmentally and hormonally regulated sialoglycoprotein expressed in type II pneumonocytes. Surfactant proteins and glycerophospholipids are transported to multilamellar structures termed lamellar bodies, which serve to store surfactant lipoprotein until secretion by exocytosis into the alveolar lumen. The cellular mechanism(s) for targeting of SP-A and other surfactant components to lamellar bodies is unknown. In the present study, we have investigated the transport of SP-A to lamellar bodies in fetal rabbit lung tissue in organ culture using pulse- chase analysis of [35S]-methionine-labeled SP-A protein. SP-A accumulated in lamellar bodies within 1-3 h of synthesis; lamellar body SP-A was found to be endoglycosidase H resistant and represented 30-40% of the radiolabeled SP- A recovered from the tissue for periods of up to 12 h postlabeling. Based on our estimates of lamellar body recovery from tissue homogenates, lamellar body-associated SP-A may account for 60-80% of the SP-A present in the fetal lung explants. Treatment of fetal rabbit lung explants with inhibitors of oligosaccharide addition (tunicamycin) and processing (castanospermine), which act within the endoplasmic reticulum, significantly reduced the rate of transport of newly synthesized SP-A to lamellar bodies. An inhibitor of oligosaccharide processing that acts on a processing step that takes place within the Golgi apparatus (swainsonine) reduced the rate of transport of radiolabeled SP-A to lamellar bodies by ~50%. These results suggest that a large proportion of newly synthesized SP-A is transported to lamellar bodies and that the transport of SP-A to lamellar bodies is enhanced by the presence of an N-linked oligosaccharide side chain and may depend on N-linked oligosaccharide processing.

KW - glycosylation

KW - lamellar bodies

KW - secretion

UR - http://www.scopus.com/inward/record.url?scp=0027393976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027393976&partnerID=8YFLogxK

M3 - Article

C2 - 8430814

AN - SCOPUS:0027393976

VL - 264

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1 8-1

ER -